IL161523A0 - Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides - Google Patents
Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptidesInfo
- Publication number
- IL161523A0 IL161523A0 IL16152302A IL16152302A IL161523A0 IL 161523 A0 IL161523 A0 IL 161523A0 IL 16152302 A IL16152302 A IL 16152302A IL 16152302 A IL16152302 A IL 16152302A IL 161523 A0 IL161523 A0 IL 161523A0
- Authority
- IL
- Israel
- Prior art keywords
- polypeptides
- pai
- pharmaceutical composition
- factor vii
- vii polypeptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101671 | 2001-11-09 | ||
| PCT/DK2002/000735 WO2003039580A1 (en) | 2001-11-09 | 2002-11-05 | Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161523A0 true IL161523A0 (en) | 2004-09-27 |
Family
ID=8160829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16152302A IL161523A0 (en) | 2001-11-09 | 2002-11-05 | Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1446146A1 (en) |
| JP (1) | JP2005510514A (en) |
| KR (1) | KR20050043733A (en) |
| CN (1) | CN1596122A (en) |
| AU (1) | AU2002340778B2 (en) |
| BR (1) | BR0213952A (en) |
| CA (1) | CA2464614A1 (en) |
| CZ (1) | CZ2004535A3 (en) |
| HU (1) | HUP0401959A3 (en) |
| IL (1) | IL161523A0 (en) |
| NO (1) | NO20042379L (en) |
| PL (1) | PL370118A1 (en) |
| RU (1) | RU2304980C2 (en) |
| WO (1) | WO2003039580A1 (en) |
| ZA (1) | ZA200403270B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009045412A2 (en) * | 2007-10-01 | 2009-04-09 | American Diagnostica, Inc. | Methods of treatment using modified plasminogen activator inhibitor type-1 molecules |
| CN111205244B (en) * | 2018-11-22 | 2023-08-18 | 上海科技大学 | Thiazolo-ring compound, preparation method, intermediate and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7907398A (en) * | 1997-06-23 | 1999-01-04 | Novo Nordisk A/S | Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function |
| AT409335B (en) * | 1998-11-10 | 2002-07-25 | Immuno Ag | PHARMACEUTICAL PREPARATION CONTAINING A RECEPTOR ANTAGONIST FOR THE TREATMENT OF BLOOD COagulation disorders |
| DE60143292D1 (en) * | 2000-05-03 | 2010-12-02 | Novo Nordisk Healthcare Ag | Variants of human coagulation factor VII |
-
2002
- 2002-11-05 HU HU0401959A patent/HUP0401959A3/en unknown
- 2002-11-05 BR BR0213952-9A patent/BR0213952A/en not_active IP Right Cessation
- 2002-11-05 WO PCT/DK2002/000735 patent/WO2003039580A1/en active IP Right Grant
- 2002-11-05 EP EP02774474A patent/EP1446146A1/en not_active Withdrawn
- 2002-11-05 PL PL02370118A patent/PL370118A1/en not_active Application Discontinuation
- 2002-11-05 IL IL16152302A patent/IL161523A0/en unknown
- 2002-11-05 AU AU2002340778A patent/AU2002340778B2/en not_active Ceased
- 2002-11-05 CN CNA028236777A patent/CN1596122A/en active Pending
- 2002-11-05 JP JP2003541871A patent/JP2005510514A/en not_active Withdrawn
- 2002-11-05 KR KR1020047006606A patent/KR20050043733A/en not_active Application Discontinuation
- 2002-11-05 CZ CZ2004535A patent/CZ2004535A3/en unknown
- 2002-11-05 CA CA002464614A patent/CA2464614A1/en not_active Abandoned
- 2002-11-05 RU RU2004117535/15A patent/RU2304980C2/en not_active IP Right Cessation
-
2004
- 2004-04-30 ZA ZA200403270A patent/ZA200403270B/en unknown
- 2004-06-08 NO NO20042379A patent/NO20042379L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002340778B2 (en) | 2007-08-02 |
| PL370118A1 (en) | 2005-05-16 |
| CN1596122A (en) | 2005-03-16 |
| EP1446146A1 (en) | 2004-08-18 |
| BR0213952A (en) | 2004-08-31 |
| KR20050043733A (en) | 2005-05-11 |
| HUP0401959A3 (en) | 2009-03-30 |
| CZ2004535A3 (en) | 2005-01-12 |
| JP2005510514A (en) | 2005-04-21 |
| HUP0401959A2 (en) | 2004-12-28 |
| RU2304980C2 (en) | 2007-08-27 |
| ZA200403270B (en) | 2004-11-08 |
| CA2464614A1 (en) | 2003-05-15 |
| RU2004117535A (en) | 2005-04-10 |
| WO2003039580A1 (en) | 2003-05-15 |
| NO20042379L (en) | 2004-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1400025I1 (en) | Phenethanolamine derivatives and pharmaceutical composition containing them | |
| HUP0400974A3 (en) | Peptide-based compounds and pharmaceutical compositions containing them | |
| EP1450824A4 (en) | Pharmaceutical composition | |
| HUP0500989A2 (en) | Animicrobial polypeptides and their uses | |
| GB0117057D0 (en) | Pharmaceutical composition | |
| GB0108470D0 (en) | Pharmaceutical compositions and their use | |
| EP1408896A4 (en) | Pharmaceutical composition | |
| HUP0400976A3 (en) | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides | |
| HUP0402318A3 (en) | Pharmaceutical composition comprising cyclosporin and use thereof | |
| GB0129117D0 (en) | Pharmaceutical composition | |
| SI1462455T1 (en) | Ser-Ser-Ser-Arg peptide and medicinal uses thereof | |
| IL159872A0 (en) | Gmg-2 polypeptides and their use | |
| IL152202A0 (en) | Human kcnq5 polypeptide and pharmaceutical compositions containing the same | |
| GB0116107D0 (en) | Pharmaceutical composition | |
| EP1379228A4 (en) | (z)-styrylbenzylsulfones and pharmaceutical uses thereof | |
| HUP0401985A3 (en) | Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides | |
| GB0127805D0 (en) | Pharmaceutical composition | |
| IL156711A0 (en) | Peptide derivatives and pharmaceutical compositions containing the same | |
| IL131266A0 (en) | Peptides and pharmaceutical compositions comprising same | |
| HUP0401959A3 (en) | Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides | |
| IL153176A (en) | Phenylpiperazines and pharmaceutical compositions comprising them | |
| AU2002340777A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides | |
| IL135442A0 (en) | Peptides and pharmaceutical compositions comprising them | |
| AU2002340784A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides | |
| AU2002340785A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides |